From: Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay
Number
Percent of population
Negative
39
7.5
Acute infection
15
2.9
Past infection
464
89.6